Literature DB >> 14667657

Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.

Greg Stratmann1, Isobel A Russell, Scott H Merrick.   

Abstract

Hemorrhage, refractory to aggressive conventional therapy, at a rate of 16 L/hr following separation from cardiopulmonary bypass for aortic arch repair, was controlled with a dose of 90 microg/kg of recombinant factor VIIa, repeated once after 2 hours.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667657     DOI: 10.1016/s0003-4975(03)01052-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

Review 1.  The use of recombinant activated coagulation factor VII for spine surgery.

Authors:  Richard B Weiskopf
Journal:  Eur Spine J       Date:  2004-05-25       Impact factor: 3.134

2.  Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma.

Authors:  D Arora; Y Mehta; N Trehan
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.